These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3120304)

  • 21. Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis.
    Campanelli AP; Brodskyn CI; Boaventura V; Silva C; Roselino AM; Costa J; Saldanha AC; de Freitas LA; de Oliveira CI; Barral-Netto M; Silva JS; Barral A
    Hum Immunol; 2010 Dec; 71(12):1220-7. PubMed ID: 20854864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis.
    Mengistu G; Akuffo HO; Yemane-Berhan T; Britton S; Fehniger TE
    Parasite Immunol; 1990 Sep; 12(5):495-507. PubMed ID: 2255561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
    Haslam PL; Parker DJ; Townsend PJ
    Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis.
    Ritter U; Moll H; Laskay T; Bröcker E; Velazco O; Becker I; Gillitzer R
    J Infect Dis; 1996 Mar; 173(3):699-709. PubMed ID: 8627035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture.
    Messadi DV; Pober JS; Murphy GF
    Lab Invest; 1988 Jan; 58(1):61-7. PubMed ID: 3121914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
    de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
    Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.
    Hernández-Ruiz J; Salaiza-Suazo N; Carrada G; Escoto S; Ruiz-Remigio A; Rosenstein Y; Zentella A; Becker I
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e871. PubMed ID: 21072232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis.
    Barral A; Jesus AR; Almeida RP; Carvalho EM; Barral-Netto M; Costa JM; Badaro R; Rocha H; Johnson WD
    Parasite Immunol; 1987 Jul; 9(4):487-97. PubMed ID: 2957642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major.
    Gaafar A; Veress B; Permin H; Kharazmi A; Theander TG; el Hassan AM
    Clin Immunol; 1999 Jun; 91(3):314-20. PubMed ID: 10370377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fungal infections inducing HLA-DR but not HLA-DQ transplantation antigens on keratinocytes.
    Johansson S; Scheynius A; Faergemann J
    Acta Derm Venereol; 1986; 66(4):277-80. PubMed ID: 2430394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare.
    Modlin RL; Horwitz DA; Jordan RR; Gebhard JF; Taylor CR; Rea TH
    Pediatr Dermatol; 1984 Jul; 2(1):26-32. PubMed ID: 6438616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
    Scheynius A; Klareskog L; Forsum U
    Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.
    Tjernlund U; Scheynius A
    Scand J Immunol; 1987 Jul; 26(1):1-6. PubMed ID: 2441455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.
    Akuffo HO; Fehniger TE; Britton S
    J Immunol; 1988 Oct; 141(7):2461-6. PubMed ID: 3171177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Parapsoriasis en plaques. Characterization of the cellular infiltrate using monoclonal antibodies].
    Büchner SA
    Z Hautkr; 1988 May; 63(5):423-4, 427-9. PubMed ID: 3043952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela.
    Lara ML; Layrisse Z; Scorza JV; Garcia E; Stoikow Z; Granados J; Bias W
    Hum Immunol; 1991 Feb; 30(2):129-35. PubMed ID: 2022495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis.
    Freitas-Teixeira PM; Silveira-Lemos D; Giunchetti RC; Baratta-Masini A; Mayrink W; Peruhype-Magalhães V; Rocha RD; Campi-Azevedo AC; Teixeira-Carvalho A; Martins-Filho OA
    Scand J Immunol; 2012 Oct; 76(4):421-32. PubMed ID: 22823491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective intralesional interferon-gamma activity in patients with lepromatous leprosy.
    Volc-Platzer B; Stemberger H; Luger T; Radaszkiewicz T; Wiedermann G
    Clin Exp Immunol; 1988 Feb; 71(2):235-40. PubMed ID: 2450707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous leishmaniasis in Ethiopia: I. Lymphocyte transformation and antibody titre.
    Schurr E; Kidane K; Yemaneberhan T; Wunderlich F
    Trop Med Parasitol; 1986 Dec; 37(4):403-8. PubMed ID: 3563321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.